Current through Register Vol. 56, No. 21, November 4, 2024
Section 8:8-13.14 - Labeling(a) The labeling for HPC shall be in accordance with the 8:8-8.8 and AABB standards as amended and supplemented.(b) There shall be documented evidence that the label used can withstand the conditions under which the specimen is stored.(c) During intermediate processing steps, the container label shall contain at least the name of the component and the unique alphanumeric identifier.(d) Prior to storage, issue, or transport, the container label(s) shall have at least the following information: 1. The name of the component, the date of collection, the alphanumeric identifiers, the recipient's name, if known, the collection facility and when applicable the donor registry's identifier, the approximate volume of the component, the names and volumes of the anticoagulants and additives, any manipulation process, the recommended storage temperature, if applicable, the expiration date and time or the statement "No expiration date", and the ABO group and Rh type of the donor; and2. A biohazard label if the donor has tested confirmed positive for infection with syphilis, Hepatitis B surface antigen, Hepatitis B core antibody, Hepatitis C virus antibody, anti-HIV-1, anti-HIV-2 and antibody to Human T-cell lymphotropic virus types I and II. N.J. Admin. Code § 8:8-13.14